scispace - formally typeset
S

Sanjay Jain

Researcher at National University of Singapore

Publications -  381
Citations -  3829

Sanjay Jain is an academic researcher from National University of Singapore. The author has contributed to research in topics: Learnability & Algorithmic learning theory. The author has an hindex of 25, co-authored 379 publications receiving 3614 citations. Previous affiliations of Sanjay Jain include Central Drug Research Institute & University of Rochester.

Papers
More filters
Book

Systems That Learn: An Introduction to Learning Theory

TL;DR: Systems That Learn presents a mathematical framework for the study of learning in a variety of domains that provides the basic concepts and techniques of learning theory as well as a comprehensive account of what is currently known about a range of learning paradigms.
Proceedings ArticleDOI

Deciding parity games in quasipolynomial time

TL;DR: It is shown that the parity game can be solved in quasipolynomial time and it is proven that coloured Muller games with n nodes and m colours can be decided in time O((mm · n)5); it is also shown that this bound cannot be improved to O((2m · n), for any c, unless FPT = W[1].
Journal ArticleDOI

Optically active antifungal azoles: synthesis and antifungal activity of (2R,3S)-2-(2,4-difluorophenyl)-3-(5-{2-[4-aryl-piperazin-1-yl]-ethyl}-tetrazol-2-yl/1-yl)-1-[1,2,4]-triazol-1-yl-butan-2-ol☆

TL;DR: A series of compounds having 3-trifluoromethyl substitution on the phenyl ring of piperazine demonstrated significant antifungal activity against variety of fungal cultures and was comparable to itraconazole and better than fluconazole.
Journal ArticleDOI

Incremental concept learning for bounded data mining

TL;DR: In this paper, a hierarchy of more and more powerful feedback learners in dependence on the number k of queries allowed to be asked is established, and the union of at most k pattern languages is shown to be iteratively inferable.
Journal ArticleDOI

Synthesis of 1-[3-(4-benzotriazol-1/2-yl-3-fluoro-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-3-substituted-thiourea derivatives as antituberculosis agents.

TL;DR: Compound 17 exhibited excellent antimycobacterial activity (in vitro) against drug sensitive and resistant clinical isolates of M. tuberculosis.